Irinotecan as 3rd Line Therapy in Gastric Cancer

Clinical trial NCT02662959 · UNKNOWN

Trial details

NCT number: NCT02662959
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasms

Start date: 2015-04-01
Primary completion: 2018-05-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.